Request a Denspath pilot
Tell us about the modeling problem you're working on. We'll get back to you within a few business days to scope a fit.
Who should reach out first
Denspath is not for every modeling team. The best early fit is an organization with a real mechanism-comparison problem, existing incumbent tools, and a buyer who has to defend the structural choice.
In-house groups working on CAR-T and adjacent cellular therapies where expansion, contraction, persistence, and target effects are all plausible.
Teams that repeatedly defend difficult mechanism choices across sponsor programs and carry a large manual review burden.
Organizations with real program pressure and budget, but not enough internal bandwidth to hand-build every challenger comparison from scratch.
Who should be in the first conversation
The pilot closes faster when the first conversation includes both the person who owns the modeling pain and the person who can judge whether the output is reviewable.
Usually the senior modeler or translational scientist who feels the workflow pain directly and can evaluate the output quality.
Usually the head of clinical pharmacology, program lead, or consulting owner who can sponsor a fixed-scope pilot.
Usually a MIDD lead, consultant, or scientific reviewer who cares whether the package is defensible in internal or external review.